Surgery Grand Rounds and Case Conference

September 18, 2013

Duke North – Room 2001

Surgical Grand Rounds

7:00 – 8:00 a.m.

“Global Perspectives in Cancer Surgery”

H. Kim Lyerly, M.D., FACS

George Barth Geller Professor of Cancer Research

Professor of Surgery

Associate Professor of Pathology

Assistant Professor of Immunology

Moderator: Jeffrey Lawson, M.D., Ph.D.

Surgical Case Conference

8:00 – 9:00 a.m.

Moderator:  Julie Sosa, M.D.

Presenter Disclosure of Financial Relationships: Dr. H. Kim Lyerly indicates that he is an Advisory Board Member for Alphavax, VentiRx and Etubics, a Founder for Argos and a Board Member for MabRx, but has no personal/financial relationships to disclose which are relative to this activity. Dr. Lawson indicates that he is a Principal Investigator for Baxter, Humacyte, and Proteon; a Consultant for Cryolife and Hemoshpere; and a Speaker for W. L. Gore, but has no personal/financial relationships to disclose which are relative to this activity.   Dr. Sosa indicates she is on the Steering Committee for Exelixis, but has no personal/financial relationships to disclose which are relative to this activity.    

RSS Activity Medical Director(s) Disclosure: Dr. Ranjan Sudan has no personal/financial relationships to disclose which are relative to this activity.

---Global Learning Objectives---

1. Review and discuss new advances in general surgery;
2. Present and discuss case studies, protocols, treatment guidelines and surgical/pathology report appropriate to General Surgery practice;
3. Review and discuss clinical research findings and other evidence from pertinent literature.

---Accreditation Information---

The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

---Unapproved Use Disclosure---

Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (Not FDA approved) ; and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and /or unsupported opinion.  Faculty at this event may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling.  This information is intended solely for continuing medical education, and is not intended to promote off-label use of these medications.  If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

---Credit Designation---

The Duke University School Of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in this activity. 

In order to receive Credit, learners must sign in at the beginning of this event.